Ingevity (NGVT) Capital Expenditures (2015 - 2026)

Ingevity (NGVT) has reported Capital Expenditures for 12 consecutive years, with $10.3 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Capital Expenditures fell 15.57% year-over-year to $10.3 million; the TTM figure through Jun 2026 stood at $56.1 million (down 13.82% YoY), while the FY2025 annual figure was $57.7 million, down 25.64% from the prior year.
• Capital Expenditures steadied at $10.3 million in Q2 2026 per NGVT's latest filing, from $10.3 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $49.2 million in Q4 2022 and bottomed at $10.0 million in Q1 2025.
• Historically, Capital Expenditures has averaged $22.7 million across 5 years, with a median of $22.6 million in 2023.
• Annual changes were most pronounced in 2022 — Capital Expenditures jumped 62.35% — and 2024, when it plunged 46.27%.
• Ingevity's Capital Expenditures stood at $49.2 million in 2022, then plunged by 40.65% to $29.2 million in 2023, then dropped by 14.73% to $24.9 million in 2024, then slipped by 5.22% to $23.6 million in 2025, then tumbled by 56.36% to $10.3 million in 2026.
• Business Quant data shows NGVT's Capital Expenditures at $10.3 million in Q2 2026, $10.3 million in Q1 2026, and $23.6 million in Q4 2025.